Hepatologist: Scott Cotler, MD

Clinical Expertise

Cirrhosis
Hepatitis B And C

Hepatocellular Carcinoma
Liver Cancer

About Dr. Cotler

Interests

Medical Education

Medical School

University of Chicago Pritzker School of Medicine

Residency

University of Chicago Medical Center - Internal Medicine: General

Fellowship

Rush-Presbyterian-St. Luke's Medical Center - Internal Medicine: Gastroenterology
University of Washington Medical Center - Internal Medicine: Hepatology

Board Certification

American Board of Internal Medicine
American Board of Internal Medicine Subspecialty Gastroenterology
Transplant Hepatology, American Board of Internal Medicine Subspecialty

Research

ABL1 Overexpressed in Hepatocellular Carcinomas, Regulates Expression of NOTCH1 and Promotes Development of Liver Tumors in Mice., Wang, F; Hou, W; Chitsike, L; Xu, Y; Bettler, C; Perera, A; Bank, T; Cotler, SJ; Dhanarajan, A; Denning, MF; Ding, X; Breslin, P; Qiang, W; Li, J; Koleske, AJ; Qiu, W, Gastroenterology
Association of HSD17B13 rs72613567:TA with non-alcoholic fatty liver disease in Hispanics/Latinos. Kallwitz, E; Tayo, BO; Kuniholm, MH; Daviglus, M; Zeng, D; Isasi, CR; Cotler, SJ, Liver international : official journal of the International Association for the Study of the Liver
Finding the Right Balance for the Use of Donation After Circulatory Death Livers for Patients With Hepatocellular Carcinoma. Lee, DD; Cotler, SJ, Liver Transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society

View All Research Show Less

Letter to the Editor: Examining HBV RNA kinetics during NA treatment - are NA multifunctional antiviral agents? Dahari, H; Vaillant, A; Cotler, SJ, Hepatology (Baltimore, Md.)
Modeling based response guided therapy in subjects with recent hepatitis C infection. Gorstein, E; Martinello, M; Churkin, A; Dasgupta, S; Walsh, K; Applegate, TL; Yardeni, D; Etzion, O; Uprichard, SL; Barash, D; Cotler, SJ; Matthews, GV; Dahari, H, Antiviral Research
Modeling-based response-guided therapy for chronic hepatitis C under glecaprevir/pibrentasvir may identify patients for ultra-short treatment duration. Dasgupta, S; Imamura, M; Gorstein, E; Nakahara, T; Tsuge, M; Churkin, A; Yardeni, D; Etzion, O; Uprichard, SL; Barash, D; Cotler, SJ; Dahari, H; Chayama, K, The Journal of infectious diseases
Modelling hepatitis D virus RNA and HBsAg dynamics during nucleic acid polymer monotherapy suggest rapid turnover of HBsAg. Shekhtman, L; Cotler, SJ; Hershkovich, L; Uprichard, SL; Bazinet, M; Pantea, V; Cebotarescu, V; Cojuhari, L; Jimbei, P; Krawczyk, A; Dittmer, U; Vaillant, A; Dahari, H, Scientific reports
MULTI-OBJECTIVE MODEL EXPLORATION OF HEPATITIS C ELIMINATION IN AN AGENT-BASED MODEL OF PEOPLE WHO INJECT DRUGS. Tatara, E; Collier, NT; Ozik, J; Gutfraind, A; Cotler, SJ; Dahari, H; Major, M; Boodram, B, Proceedings of the ... Winter Simulation Conference. Winter Simulation Conference
Objectively measured sedentary time physical activity and liver enzyme elevations in US Hispanics/Latinos., Li, J; Hua, S; Chen, GC; Strizich, G; Kuniholm, MH; Shan, Z; Talavera, GA; Castañeda, SF; Gellman, MD; Cai, J; Cotler, SJ; Zhang, X; Hu, FB; Kaplan, R; Isasi, CR; Qi, Q, Liver international : official journal of the International Association for the Study of the Liver
Response guided therapy for reducing duration of direct acting antivirals in chronic hepatitis C infected patients: a Pilot study. Etzion, O; Dahari, H; Yardeni, D; Issachar, A; Nevo-Shor, A; Cohen-Naftaly, M; Ashur, Y; Uprichard, SL; Arbib, OS; Munteanu, D; Braun, M; Cotler, SJ; Abufreha, N; Keren-Naus, A; Shemer-Avni, Y; Mor, O; Murad, J; Novack, V; Shlomai, A, Scientific reports
A randomized proof-of-concept clinical trial on repurposing chlorcyclizine for the treatment of chronic hepatitis C., Koh, C; Dubey, P; Han, MAT; Walter, PJ; Garraffo, HM; Surana, P; Southall, NT; Borochov, N; Uprichard, SL; Cotler, SJ; Etzion, O; Heller, T; Dahari, H; Liang, TJ, Antiviral Research
American Ancestry Is a Risk Factor for Suspected Nonalcoholic Fatty Liver Disease in Hispanic/Latino Adults. Kallwitz, ER; Tayo, BO; Kuniholm, MH; Cai, J; Daviglus, M; Cooper, RS; Cotler, SJ, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
Barriers to treatment of chronic hepatitis C with direct acting antivirals in an urban clinic. Malespin, M; Harris, C; Kanar, O; Jackman, K; Smotherman, C; Johnston, A; Ferm, J; de Melo, SW; Scolapio, JS; Nelson, DR; Cotler, SJ, Annals of hepatology
Focal Adhesion Kinase and ß-Catenin Cooperate to Induce Hepatocellular Carcinoma. Shang, N; Wang, H; Bank, T; Perera, A; Joyce, C; Kuffel, G; Zilliox, MJ; Cotler, SJ; Ding, X; Dhanarajan, A; Breslin, P; Qiu, W, Hepatology (Baltimore, Md.)
Modeling indicates efficient vaccine-based interventions for the elimination of hepatitis C virus among persons who inject drugs in metropolitan Chicago. Echevarria, D; Gutfraind, A; Boodram, B; Layden, J; Ozik, J; Page, K; Cotler, SJ; Major, M; Dahari, H, Vaccine
Modeling suggests that microliter volumes of contaminated blood caused an outbreak of hepatitis C during computerized tomography. Shteyer, E; Shekhtman, L; Zinger, T; Harari, S; Gafanovich, I; Wolf, D; Ivgi, H; Barsuk, R; Dery, I; Armoni, D; Rivkin, M; Pipalia, R; Cohen Eliav, M; Skorochod, Y; Breuer, GS; Tur-Kaspa, R; Weil Wiener, Y; Stern, A; Cotler, SJ; Dahari, H; Lurie, Y, PLoS ONE
Plasma Hepatitis E Virus Kinetics in Solid Organ Transplant Patients Receiving Ribavirin. Lhomme, S; DebRoy, S; Kamar, N; Abravanel, F; Metsu, D; Marion, O; Dimeglio, C; Cotler, SJ; Izopet, J; Dahari, H, Viruses
Early HCV viral kinetics under DAAs may optimize duration of therapy in patients with compensated cirrhosis. Gambato, M; Canini, L; Lens, S; Graw, F; Perpiñan, E; Londoño, MC; Uprichard, SL; Mariño, Z; Reverter, E; Bartres, C; González, P; Pla, A; Costa, J; Burra, P; Cotler, SJ; Forns, X; Dahari, H, Liver international : official journal of the International Association for the Study of the Liver
Gender disparities in liver transplant candidates with nonalcoholic steatohepatitis. Loy, VM; Joyce, C; Bello, S; VonRoenn, N; Cotler, SJ, Clinical transplantation
Inhibition of insulin-like growth factor 1 receptor enhances the efficacy of sorafenib in inhibiting hepatocellular carcinoma cell growth and survival. Wang, F; Bank, T; Malnassy, G; Arteaga, M; Shang, N; Dalheim, A; Ding, X; Cotler, SJ; Denning, MF; Nishimura, MI; Breslin, P; Qiu, W, Hepatology communications
Modeling of patient virus titers suggests that availability of a vaccine could reduce hepatitis C virus transmission among injecting drug users. Major, M; Gutfraind, A; Shekhtman, L; Cui, Q; Kachko, A; Cotler, SJ; Hajarizadeh, B; Sacks-Davis, R; Page, K; Boodram, B; Dahari, H, Science translational medicine
Studies on the Tissue Localization of HKDC1 a Putative Novel Fifth Hexokinase, in Humans, Khan, M. W.; Ding, X.; Cotler, S. J.; Clarke, M.; Layden, B. T., The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society
Adverse Effect of Post-Discharge Care Fragmentation on Outcomes after Readmissions after Liver Transplantation Kothari, A. N.; Loy, V. M.; Brownlee, S. A.; Ezure, Y.; Schaidle-Blackburn, C.; Cotler, S. J.; di Sabato, D.; Kuo, P. C.; Lu, A. D., Journal of the American College of Surgeons
Associations of Insulin Resistance and Glycemia With Liver Enzymes in Hispanic/Latino Youths: Results From the Hispanic Community Children's Health Study/Study of Latino Youth (SOL Youth) Parrinello, C. M.; Rudolph, B. J.; Lazo, M.; Gallo, L. C.; Thyagarajan, B.; Cotler, S. J.; Qi, Q.; Seeherunvong, T.; Vidot, D. C.; Strickler, H. D.; Kaplan, R. C.; Isasi, C. R., Journal of clinical gastroenterology
Case Series of 10 Patients with Cirrhosis Undergoing Emergent Repair of Ruptured Umbilical Hernias: Natural History and Predictors of Outcomes. Malespin, M; Moore, CM; Fialho, A; de Melo, SW; Benyashvili, T; Kothari, AN; di Sabato, D; Kallwitz, ER; Cotler, SJ; Lu, AD, Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation
Early Hospital Readmissions and Mortality in Patients With Decompensated Cirrhosis Enrolled in a Large National Health Insurance Administrative Database Scaglione, S. J.; Metcalfe, L.; Kliethermes, S.; Vasilyev, I.; Tsang, R.; Caines, A.; Mumtaz, S.; Goyal, V.; Khalid, A.; Shoham, D.; Markossian, T.; Luke, A.; Underwood, H.; Cotler, S. J., Journal of clinical gastroenterology
End of treatment RNA-positive/sustained viral response in an individual with acute hepatitis C virus infection treated with direct-acting antivirals Shteyer, E.; Dahari, H.; Gafanovich, I.; Dery, I.; Wolf, D.; Cotler, S. J.; Lurie, Y., Therapeutic advances in gastroenterology
Features of hepatocellular carcinoma in Hispanics differ from African Americans and non-Hispanic Whites. Venepalli, NK; Modayil, MV; Berg, SA; Nair, TD; Parepally, M; Rajaram, P; Gaba, RC; Bui, JT; Huang, Y; Cotler, SJ, WORLD JOURNAL OF HEPATOLOGY
Genome-wide association study of iron traits and relation to diabetes in the Hispanic Community Health Study/Study of Latinos (HCHS/SOL): potential genomic intersection of iron and glucose regulation? Raffield, L. M.; Louie, T.; Sofer, T.; Jain, D.; Ipp, E.; Taylor, K. D.; Papanicolaou, G. J.; Aviles-Santa, L.; Lange, L. A.; Laurie, C. C.; Conomos, M. P.; Thornton, T. A.; Chen, Y. I.; Qi, Q.; Cotler, S.; Thyagarajan, B.; Schneiderman, N.; Rotter, J. I.; Reiner, A. P.; Lin, H. J., Human molecular genetics
HCV kinetic and modeling analyses project shorter durations to cure under combined therapy with daclatasvir and asunaprevir in chronic HCV-infected patients Canini, L.; Imamura, M.; Kawakami, Y.; Uprichard, S. L.; Cotler, S. J.; Dahari, H.; Chayama, K., PLoS ONE
Modeling HCV cure after an ultra-short duration of therapy with direct acting agents Goyal, A.; Lurie, Y.; Meissner, E. G.; Major, M.; Sansone, N.; Uprichard, S. L.; Cotler, S. J.; Dahari, H., Antiviral Research
Pharmacokinetics and pharmacodynamics modeling of lonafarnib in patients with chronic hepatitis delta virus infection Canini, L.; Koh, C.; Cotler, S. J.; Uprichard, S. L.; Winters, M. A.; Han, M. A. T.; Kleiner, D. E.; Idilman, R.; Yurdaydin, C.; Glenn, J. S.; Heller, T.; Dahari, H., Hepatology communications
Prevalence of end of treatment RNA-positive/sustained viral response in HCV patients treated with sofosbuvir combination therapies Malespin, M.; Benyashvili, T.; Uprichard, S. L.; Perelson, A. S.; Dahari, H.; Cotler, S. J., Therapeutic advances in gastroenterology
An assessment of racial differences in the upper limits of normal ALT levels in children and the effect of obesity on elevated values Kliethermes, S.; Ma, M.; Purtell, C.; Balasubramanian, N.; Gonzalez, B.; Layden, T. J.; Cotler, S. J., Pediatric obesity
Cure prevents more than transmission of HCV Dahari, H.; Cotler, S. J.; Feld, J. J., Hepatology (Baltimore, Md.)
FAK kinase activity is required for the progression of c-Met/beta-catenin-driven HCC Breslin, P.; Kuo, P.; Ding, X.; Cotler, S.; Nishimura, M.; Zhang, J.; Qiu, W.; Arteaga, M.; Zaidi, A.; Shang, N., Gene expression
HCV kinetic and modeling analyses indicate similar time to cure among sofosbuvir combination regimens with daclatasvir simeprevir or ledipasvir, Dahari, H.; Canini, L.; Graw, F.; Uprichard, S. L.; Araujo, E. S.; Penaranda, G.; Coquet, E.; Chiche, L.; Riso, A.; Renou, C.; Bourliere, M.; Cotler, S. J.; Halfon, P., Journal of Hepatology
Hepatitis B Stigma and Knowledge among Vietnamese in Ho Chi Minh City and Chicago Dam, L.; Cheng, A.; Tran, P.; Wong, S. S.; Hershow, R.; Cotler, S.; Cotler, S. J., Canadian journal of gastroenterology & hepatology
Hepatitis B Stigma and Knowledge among Vietnamese in Ho Chi Minh City and Chicago Dam, L.; Cheng, A.; Tran, P.; Wong, S. S.; Hershow, R.; Cotler, S.; Cotler, S. J., Canadian journal of gastroenterology & hepatology
Hepatitis C virus cures after direct acting antiviral-related drug-induced liver injury: Case report Hasin, Y.; Shteingart, S.; Dahari, H.; Gafanovich, I.; Floru, S.; Braun, M.; Shlomai, A.; Verstandig, A.; Dery, I.; Uprichard, S. L.; Cotler, S. J.; Lurie, Y., WORLD JOURNAL OF HEPATOLOGY
Inhibition of SIRT2 suppresses hepatic fibrosis Arteaga, M.; Shang, N.; Ding, X.; Yong, S.; Cotler, S. J.; Denning, M. F.; Shimamura, T.; Breslin, P.; Luscher, B.; Qiu, W., American journal of physiology.Gastrointestinal and liver physiology
Personality Coping, and Well-Being for People Living with Chronic Hepatitis C., Cellar, DF; Voster, D; Fetters, R; Twitchell, E; Harper, GW; Scott, C, Psychological reports
Protease inhibitors partially overcome the interferon nonresponse phenotype in patients with chronic hepatitis C. Duarte-Rojo, A; Fischer, SE; Adeyi, O; Zita, D; Deneke, MG; Selzner, N; Chen, L; Malespin, M; Cotler, SJ; McGilvray, ID; Feld, JJ, Journal of viral hepatitis
Resurrection of response-guided therapy for sofosbuvir combination therapies Dahari, H.; Halfon, P.; Cotler, S. J., Journal of Hepatology
Retinoid and carotenoid status in serum and liver among patients at high-risk for liver cancer Kataria, Y.; Deaton, R. J.; Enk, E.; Jin, M.; Petrauskaite, M.; Dong, L.; Goldenberg, J. R.; Cotler, S. J.; Jensen, D. M.; van Breemen, R. B.; Gann, P. H., BMC GASTROENTEROLOGY
The time and cost investment required to obtain and initiate direct-acting antiviral therapy Loy, V.; Benyashvili, T.; Adams, W.; Pavkov, D.; O'Mahoney, M.; Cotler, S. J., ANTIVIRAL THERAPY
FAK is required for c-Met/beta-catenin-driven hepatocarcinogenesis Shang, N.; Arteaga, M.; Zaidi, A.; Stauffer, J.; Cotler, S. J.; Zeleznik-Le, N. J.; Zhang, J.; Qiu, W., Hepatology (Baltimore, Md.)
Mathematical Modeling of Hepatitis C Prevalence Reduction with Antiviral Treatment Scale-Up in Persons Who Inject Drugs in Metropolitan Chicago Echevarria, D.; Gutfraind, A.; Boodram, B.; Major, M.; Del Valle, S.; Cotler, S. J.; Dahari, H., PLoS ONE
Oral prenylation inhibition with lonafarnib in chronic hepatitis D infection: a proof-of-concept randomised double-blind, placebo-controlled phase 2A trial, Koh, C.; Canini, L.; Dahari, H.; Zhao, X.; Uprichard, S. L.; Haynes-Williams, V.; Winters, M. A.; Subramanya, G.; Cooper, S. L.; Pinto, P.; Wolff, E. F.; Bishop, R.; Ai Thanda Han, M.; Cotler, S. J.; Kleiner, D. E.; Keskin, O.; Idilman, R.; Yurdaydin, C.; Glenn, J. S.; Heller, T., The Lancet.Infectious diseases
Prevalence and correlates of suspected nonalcoholic fatty liver disease in Chinese American children Malespin, M.; Sleesman, B.; Lau, A.; Wong, S. S.; Cotler, S. J., Journal of clinical gastroenterology
Prevalence of suspected nonalcoholic fatty liver disease in Hispanic/Latino individuals differs by heritage Kallwitz, E. R.; Daviglus, M. L.; Allison, M. A.; Emory, K. T.; Zhao, L.; Kuniholm, M. H.; Chen, J.; Gouskova, N.; Pirzada, A.; Talavera, G. A.; Youngblood, M. E.; Cotler, S. J., Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
Reply: To PMID 25098971. Guedj, J; Canini, L; Cotler, S; Dahari, H, Hepatology (Baltimore, Md.)
Severity of liver disease affects HCV kinetics in patients treated with intravenous silibinin monotherapy. Canini, L; DebRoy, S; Mariño, Z; Conway, JM; Crespo, G; Navasa, M; D'Amato, M; Ferenci, P; Cotler, SJ; Forns, X; Perelson, AS; Dahari, H, ANTIVIRAL THERAPY
Sustained virological response with intravenous silibinin: individualized IFN-free therapy via real-time modelling of HCV kinetics Dahari, H.; Shteingart, S.; Gafanovich, I.; Cotler, S. J.; D'Amato, M.; Pohl, R. T.; Weiss, G.; Ashkenazi, Y. J.; Tichler, T.; Goldin, E.; Lurie, Y., Liver international : official journal of the International Association for the Study of the Liver
The distribution of Hepatitis B virus exposure and infection in a population-based sample of US Hispanic adults Jung, M.; Kuniholm, M. H.; Ho, G. Y.; Cotler, S.; Strickler, H. D.; Thyagarajan, B.; Youngblood, M.; Kaplan, R. C.; Del Amo, J., Hepatology (Baltimore, Md.)
Association of genetic variants with rapid fibrosis: progression after liver transplantation for hepatitis C Layden, J. E.; Tayo, B. O.; Cotler, S. J.; Clark, N. M.; Baraoidan, K.; Friedman, S. L.; Cooper, R. S., Transplantation
Biomechanics and functionality of hepatocytes in liver cirrhosis. Sun, S; Song, Z; Cotler, SJ; Cho, M, Journal of Biomechanics
Imaging surveillance and multidisciplinary review improves curative therapy access and survival in HCC patients. Gaba, RC; Kallwitz, ER; Parvinian, A; Bui, JT; Von Roenn, NM; Berkes, JL; Cotler, SJ, Annals of hepatology
Individualized treatment for patients with low HCV load (genotype 1): a viral kinetic approach Dahari, H.; Cotler, S. J., Hepatology (Baltimore, Md.)
Presurgical transarterial chemoembolization does not increase biliary stricture incidence in orthotopic liver transplant patients Casadaban, L.; Malespin, M.; Cheung, A.; McGuffey, R. A.; Boulay, B. R.; Halline, A. G.; Brown, R. D.; Cotler, S. J.; Jeon, H.; Bui, J. T.; Gaba, R. C., Transplantation proceedings
Prevalence of hepatitis C virus infection in US Hispanic/Latino adults: results from the NHANES 2007-2010 and HCHS/SOL studies. Kuniholm, MH; Jung, M; Everhart, JE; Cotler, S; Heiss, G; McQuillan, G; Kim, RS; Strickler, HD; Thyagarajan, B; Youngblood, M; Kaplan, RC; Ho, GY, The Journal of infectious diseases
Understanding early serum hepatitis D virus and hepatitis B surface antigen kinetics during pegylated interferon-alpha therapy via mathematical modeling Guedj, J.; Rotman, Y.; Cotler, S. J.; Koh, C.; Schmid, P.; Albrecht, J.; Haynes-Williams, V.; Liang, T. J.; Hoofnagle, J. H.; Heller, T.; Dahari, H., Hepatology (Baltimore, Md.)
Modeling shows that the NS5A inhibitor daclatasvir has two modes of action and yields a shorter estimate of the hepatitis C virus half-life Guedj, J.; Dahari, H.; Rong, L.; Sansone, N. D.; Nettles, R. E.; Cotler, S. J.; Layden, T. J.; Uprichard, S. L.; Perelson, A. S., Proceedings of the National Academy of Sciences of the United States of America
Phase 1 study of N(1) N(11)-diethylnorspermine (DENSPM) in patients with advanced hepatocellular carcinoma., Goyal, L; Supko, JG; Berlin, J; Blaszkowsky, LS; Carpenter, A; Heuman, DM; Hilderbrand, SL; Stuart, KE; Cotler, S; Senzer, NN; Chan, E; Berg, CL; Clark, JW; Hezel, AF; Ryan, DP; Zhu, AX, CANCER CHEMOTHERAPY AND PHARMACOLOGY
Physical activity and metabolic syndrome in liver transplant recipients Kallwitz, E. R.; Loy, V.; Mettu, P.; Von Roenn, N.; Berkes, J.; Cotler, S. J., Liver Transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society
Prognostic capability of different liver disease scoring systems for prediction of early mortality after transjugular intrahepatic portosystemic shunt creation Gaba, R. C.; Couture, P. M.; Bui, J. T.; Knuttinen, M. G.; Walzer, N. M.; Kallwitz, E. R.; Berkes, J. L.; Cotler, S. J., Journal of vascular and interventional radiology : JVIR
Quantitative morphometric analysis of hepatocellular carcinoma: development of a programmed algorithm and preliminary application Yap, F. Y.; Bui, J. T.; Knuttinen, M. G.; Walzer, N. M.; Cotler, S. J.; Owens, C. A.; Berkes, J. L.; Gaba, R. C., Diagnostic and interventional radiology (Ankara, Turkey)
Understanding triphasic HCV decline during treatment in the era of IL28B polymorphisms and direct acting antiviral agents via mathematical modeling Dahari, H.; Cotler, S. J.; Layden, T. J.; Perelson, A. S., Journal of Hepatology
Barriers to treatment of hepatitis B in an urban Chinatown community Malespin, M.; Wong, S.; Siqueira, F.; Luc, B.; Ravaee, B.; Vainder, C.; Cotler, S. J., Journal of clinical gastroenterology
Characterizing hepatitis B stigma in Chinese immigrants Cotler, S. J.; Cotler, S.; Xie, H.; Luc, B. J.; Layden, T. J.; Wong, S. S., Journal of viral hepatitis
Characterizing hepatitis B stigma in Chinese immigrants Cotler, S. J.; Cotler, S.; Xie, H.; Luc, B. J.; Layden, T. J.; Wong, S. S., Journal of viral hepatitis
Impact of donor and recipient race on survival after hepatitis C-related liver transplantation Layden, J. E.; Cotler, S. J.; Grim, S. A.; Fischer, M. J.; Lucey, M. R.; Clark, N. M., Transplantation
Racial differences in fibrosis progression after HCV-related liver transplantation Layden, J. E.; Cotler, S.; Brown, K. A.; Lucey, M. R.; Te, H. S.; Eswaran, S.; Fimmel, C.; Layden, T. J.; Clark, N. M., Transplantation
TIPS for treatment of variceal hemorrhage: clinical outcomes in 128 patients at a single institution over a 12-year period Gaba, R. C.; Omene, B. O.; Podczerwinski, E. S.; Knuttinen, M. G.; Cotler, S. J.; Kallwitz, E. R.; Berkes, J. L.; Walzer, N. M.; Bui, J. T.; Owens, C. A., Journal of vascular and interventional radiology : JVIR
Potential treatment options and future research to increase hepatitis C virus treatment response rate Tencate, V.; Sainz, B., Jr; Cotler, S. J.; Uprichard, S. L., Hepatic medicine : evidence and research
Laboratory diagnosis and nonoperative management of biliary complications in living donor liver transplant patients Venu, M.; Brown, R. D.; Lepe, R.; Berkes, J.; Cotler, S. J.; Benedetti, E.; Testa, G.; Venu, R. P., Journal of clinical gastroenterology
Hepatic ischemia/reperfusion injury can be modulated with thymoglobulin induction therapy. Bogetti, D.; Jarzembowski, T. M.; Sankary, H. N.; Manzelli, A.; Knight, P. S.; Chejfec, G.; Cotler, S.; Oberholzer, J.; Testa, G.; Benedetti, E., Transplantation proceedings
Thymoglobulin induction protects liver allografts from ischemia/reperfusion injury. Bogetti, D.; Sankary, H. N.; Jarzembowski, T. M.; Manzelli, A.; Knight, P. S.; Thielke, J.; Chejfec, G.; Cotler, S.; Oberholzer, J.; Testa, G.; Benedetti, E., Clinical transplantation